Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
175 Leser
Artikel bewerten:
(0)

Research and Markets - Radiation Oncology Market to Reach $10 Billion by 2025 - Key Vendors are Varian Medical, Elekta AB, Accuray, Ion Beam Applications, C.R. Bard, IsoRay, Mevion Medical, Nordion, NTP & Mallinckrodt

DUBLIN, May 23, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Radiation Oncology Market 2014 - 2025" report to their offering.

Research and Markets Logo

The global radiation oncology market is expected to reach USD 10.1 billion by 2025. Rising prevalence of cancer is the prime factor responsible for substantial growth of radiation oncology market over the forecast period.

Technological advancements in radiotherapy resulted in increased adoption of radiation oncology as primary treatment line of cancer. Development of compact advanced radiotherapy options such as CyberKnife, Gamma Knife, and tomotherapy complemented this growth. These advanced methods pose lesser postoperative complications and faster recovery time.

Increasing per capita healthcare expenditure is also an important macroeconomic factor driving the market growth. In addition, with the aid of supportive government initiatives and awareness, patients are not hesitant to opt for advanced treatment options. For instance, per capita health expenditure witnessed exponential growth of more than 55.0% from 1995 to 2014, as stated by the World Bank Group.

North America held maximum share in global radiation oncology market in 2016. Developed health infrastructure, presence of many multinational players, and greater per capita health infrastructure are the key factors contributing to the dominance of this region over the forecast period.

However, uncertain health reforms post the U.S. presidential election of 2016 coupled with shortage in supply of radiopharmaceuticals is likely to hinder the growth in this region.

Companies Mentioned

  • Varian Medical Systems
  • Elekta AB
  • Accuray Incorporated
  • Ion Beam Applications SA
  • C.RBard, Inc.
  • Isoray Medical, Inc.
  • Mevion Medical Systems, Inc.
  • Nordian Inc.
  • NTP Radioisotopes
  • Mallinckrodt Public Limited Company

Key Topics Covered:

1. Methodology and Scope

2. Executive Summary

3. Radiation Oncology Market Variables, Trends & Scope

4. Radiation Oncology: Product Estimates & Trend Analysis

5. Radiation Oncology: Application Estimates & Trend Analysis

6. Radiation Oncology: Technology Estimates & Trend Analysis

7. Radiation Oncology: Regional Estimates & Trend Analysis

8. Competitive Landscape

For more information about this report visit http://www.researchandmarkets.com/research/b34xpq/radiation

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.